Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1989 Feb;52(2):207–212. doi: 10.1136/jnnp.52.2.207

A double-blind crossover comparison of Sinemet CR4 and standard Sinemet 25/100 in patients with Parkinson's disease and fluctuating motor performance.

J M Cedarbaum 1, M Hoey 1, F H McDowell 1
PMCID: PMC1032507  PMID: 2649640

Abstract

Fourteen Parkinsonian patients with fluctuations in therapeutic response to levodopa completed a double-blind, crossover trial of controlled-release levodopa/carbidopa (Sinemet CR4) vs standard Sinemet 25/100 (STD). Significant increases in mean interdose interval and per cent of the waking day spent "on", as well as reductions in the number of daily medication doses and number of "off" episodes were noted. In the double-blind part of the study, relative to open treatment with STD, ten patients rated themselves as improved while taking CR4, whereas only three considered themselves improved with STD. Difficulties using CR4 included an increased "lag-time" to the onset of antiparkinson effect, a tendency to produce increasingly severe dyskinesia late in the day, and a somewhat lessened predictability of motor response. Nonetheless, since the overall level of motor function through the day was equal to or better than that attained with STD, but with fewer medication administrations, Sinemet CR4 should prove a useful antiparkinsonian agent.

Full text

PDF
207

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barbeau A., Campanella G., Butterworth R. F., Yamada K. Uptake and efflux of 14-C-dopamine in platelets: evidence for a generalized defect in Parkinson's disease. Neurology. 1975 Jan;25(1):1–9. doi: 10.1212/wnl.25.1.1. [DOI] [PubMed] [Google Scholar]
  2. Cedarbaum J. M., Breck L., Kutt H., McDowell F. H. Controlled-release levodopa/carbidopa. I. Sinemet CR3 treatment of response fluctuations in Parkinson's disease. Neurology. 1987 Feb;37(2):233–241. doi: 10.1212/wnl.37.2.233. [DOI] [PubMed] [Google Scholar]
  3. Cedarbaum J. M., Breck L., Kutt H., McDowell F. H. Controlled-release levodopa/carbidopa. II. Sinemet CR4 treatment of response fluctuations in Parkinson's disease. Neurology. 1987 Oct;37(10):1607–1612. doi: 10.1212/wnl.37.10.1607-a. [DOI] [PubMed] [Google Scholar]
  4. Cedarbaum J. M., Hoey M., Kutt H., McDowell F. H. Controlled-release levodopa/carbidopa. III: Sinemet CR5 treatment of response fluctuations in Parkinson's disease. Clin Neuropharmacol. 1988 Apr;11(2):168–173. [PubMed] [Google Scholar]
  5. Fahn S. "On-off" phenomenon with levodopa therapy in Parkinsonism. Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine. Neurology. 1974 May;24(5):431–441. doi: 10.1212/wnl.24.5.431. [DOI] [PubMed] [Google Scholar]
  6. Goetz C. G., Tanner C. M., Klawans H. L., Shannon K. M., Carroll V. S. Parkinson's disease and motor fluctuations: long-acting carbidopa/levodopa (CR-4-Sinemet). Neurology. 1987 May;37(5):875–878. doi: 10.1212/wnl.37.5.875. [DOI] [PubMed] [Google Scholar]
  7. Hardie R. J., Lees A. J., Stern G. M. On-off fluctuations in Parkinson's disease. A clinical and neuropharmacological study. Brain. 1984 Jun;107(Pt 2):487–506. doi: 10.1093/brain/107.2.487. [DOI] [PubMed] [Google Scholar]
  8. Hardie R. J., Malcolm S. L., Lees A. J., Stern G. M., Allen J. G. The pharmacokinetics of intravenous and oral levodopa in patients with Parkinson's disease who exhibit on-off fluctuations. Br J Clin Pharmacol. 1986 Oct;22(4):429–436. doi: 10.1111/j.1365-2125.1986.tb02913.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Juncos J., Serrati C., Fabbrini G., Chase T. N. Fluctuating levodopa concentrations and Parkinson's disease. Lancet. 1985 Aug 24;2(8452):440–440. doi: 10.1016/s0140-6736(85)92754-0. [DOI] [PubMed] [Google Scholar]
  10. Mouradian M. M., Juncos J. L., Fabbrini G., Chase T. N. Motor fluctuations in Parkinson's disease: pathogenetic and therapeutic studies. Ann Neurol. 1987 Oct;22(4):475–479. doi: 10.1002/ana.410220406. [DOI] [PubMed] [Google Scholar]
  11. Nutt J. G., Woodward W. R., Anderson J. L. The effect of carbidopa on the pharmacokinetics of intravenously administered levodopa: the mechanism of action in the treatment of parkinsonism. Ann Neurol. 1985 Nov;18(5):537–543. doi: 10.1002/ana.410180505. [DOI] [PubMed] [Google Scholar]
  12. Nutt J. G., Woodward W. R., Carter J. H. Clinical and biochemical studies with controlled-release levodopa/carbidopa. Neurology. 1986 Sep;36(9):1206–1211. doi: 10.1212/wnl.36.9.1206. [DOI] [PubMed] [Google Scholar]
  13. Nutt J. G., Woodward W. R., Carter J. H. Clinical and biochemical studies with controlled-release levodopa/carbidopa. Neurology. 1986 Sep;36(9):1206–1211. doi: 10.1212/wnl.36.9.1206. [DOI] [PubMed] [Google Scholar]
  14. Poewe W. H., Lees A. J., Stern G. M. Treatment of motor fluctuations in Parkinson's disease with an oral sustained-release preparation of L-dopa: clinical and pharmacokinetic observations. Clin Neuropharmacol. 1986;9(5):430–439. doi: 10.1097/00002826-198610000-00003. [DOI] [PubMed] [Google Scholar]
  15. Sage J. I., Mark M. H. Comparison of controlled-release Sinemet (CR4) and standard Sinemet (25 mg/100 mg) in advanced Parkinson's disease: a double-blind, crossover study. Clin Neuropharmacol. 1988 Apr;11(2):174–179. doi: 10.1097/00002826-198804000-00009. [DOI] [PubMed] [Google Scholar]
  16. Spencer S. E., Wooten G. F. Altered pharmacokinetics of L-dopa metabolism in rat striatum deprived of dopaminergic innervation. Neurology. 1984 Aug;34(8):1105–1108. doi: 10.1212/wnl.34.8.1105. [DOI] [PubMed] [Google Scholar]
  17. Sweet R. D., McDowell F. H. Plasma dopa concentrations and the "on-off" effect after chronic treatment of Parkinson's disease. Neurology. 1974 Oct;24(10):953–956. doi: 10.1212/wnl.24.10.953. [DOI] [PubMed] [Google Scholar]
  18. Tolosa E. S., Martin W. E., Cohen H. P., Jacobson R. L. Patterns of clinical response and plasma dopa levels in Parkinson's disease. Neurology. 1975 Feb;25(2):177–183. doi: 10.1212/wnl.25.2.177. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES